Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret L MacMillan

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Blood|March 28, 2009
Where is the start line?Margaret L MacMillan
British Journal of Haematology|February 9, 2010
Haematopoeitic cell transplantation for Fanconi anaemia - when and how?Margaret L MacMillan, John E Wagner
Current Opinion in Oncology|February 24, 2005
Hematopoietic cell transplantation for congenital bone marrow failureMargaret L MacMillan, John E Wagner
Pediatric Clinics of North America|March 24, 2010
Management of acute graft-versus-host disease in childrenPaul A Carpenter, Margaret L Macmillan
Seminars in Hematology|January 30, 2010
Transplant outcomes in bone marrow failure syndromes and hemoglobinopathiesMargaret L MacMillan, Mark C Walters, Eliane Gluckman
Blood|April 15, 2010
The best endpoint for acute GVHD treatment trialsMargaret L MacMillan, Todd E DeFor, Daniel J Weisdorf
Frontiers in Pediatrics|August 13, 2021
A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is KeyAsmaa Ferdjallah, Jo-Anne H Young, Margaret L MacMillan
Expert Review of Hematology|December 9, 2016
Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendationsChristen L Ebens, Margaret L MacMillan, John E Wagner
British Journal of Haematology|April 11, 2012
What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk scoreMargaret L MacMillan, Todd E DeFor, Daniel J Weisdorf
American Journal of Medical Genetics. Part A|October 8, 2016
Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutationsRebecca Tryon, Heather Zierhut, Margaret L MacMillan, et al.
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Blood|March 28, 2009
Where is the start line?Margaret L MacMillan
British Journal of Haematology|February 9, 2010
Haematopoeitic cell transplantation for Fanconi anaemia - when and how?Margaret L MacMillan, John E Wagner
Current Opinion in Oncology|February 24, 2005
Hematopoietic cell transplantation for congenital bone marrow failureMargaret L MacMillan, John E Wagner
Pediatric Clinics of North America|March 24, 2010
Management of acute graft-versus-host disease in childrenPaul A Carpenter, Margaret L Macmillan
Seminars in Hematology|January 30, 2010
Transplant outcomes in bone marrow failure syndromes and hemoglobinopathiesMargaret L MacMillan, Mark C Walters, Eliane Gluckman
Blood|April 15, 2010
The best endpoint for acute GVHD treatment trialsMargaret L MacMillan, Todd E DeFor, Daniel J Weisdorf
Frontiers in Pediatrics|August 13, 2021
A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is KeyAsmaa Ferdjallah, Jo-Anne H Young, Margaret L MacMillan
Expert Review of Hematology|December 9, 2016
Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendationsChristen L Ebens, Margaret L MacMillan, John E Wagner
British Journal of Haematology|April 11, 2012
What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk scoreMargaret L MacMillan, Todd E DeFor, Daniel J Weisdorf
American Journal of Medical Genetics. Part A|October 8, 2016
Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutationsRebecca Tryon, Heather Zierhut, Margaret L MacMillan, et al.
Pageof 17